Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AML

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Not yet recruiting	Phase 2	2026-10-09		NCT07867626

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Rutgers, The State University of New Jersey	154

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Rutgers Cancer Institute	New Brunswick	United States	2

Clinical trials